Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
97.99
+2.01 (2.09%)
Feb 11, 2026, 4:00 PM EST - Market closed

Revolution Medicines Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
18,9438,0834,7202,1151,8552,628
Market Cap Growth
150.51%71.26%123.15%14.03%-29.43%-
Enterprise Value
17,4276,6203,9691,5251,2782,195
Last Close Price
97.9943.7428.6823.8225.1739.59
PS Ratio
--407.5859.7863.1161.14
PB Ratio
11.643.572.583.093.085.54
P/TBV Ratio
12.413.682.693.463.516.58
EV/Sales Ratio
--342.7843.1143.4851.07
Debt / Equity Ratio
0.260.060.050.090.110.07
Asset Turnover
--0.010.050.050.11
Quick Ratio
7.8613.9712.8910.489.669.48
Current Ratio
8.0514.2013.0610.659.779.63
Return on Equity (ROE)
-60.76%-29.33%-34.75%-38.63%-34.73%-34.49%
Return on Assets (ROA)
-32.29%-18.66%-20.08%-20.83%-18.00%-17.56%
Return on Capital Employed (ROCE)
-51.70%-28.80%-24.10%-34.40%-27.70%-21.30%
Earnings Yield
-5.07%-7.42%-9.25%-11.76%-10.09%-4.12%
FCF Yield
-4.10%-7.02%-7.59%-11.12%-8.29%-3.92%
Buyback Yield / Dilution
-15.98%-48.24%-40.34%-10.74%-32.68%-1879.16%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q